Adeno-associated virus (AAV) vectored products are currently leading candidates for gene therapy applications with multiple approved products and many more in clinical trials.
Stanford inventors have developed a method to create spatially micropatterned vascularized structures that enable in vitro representation of human and animal biology in models such as cells, tissues, organs, and organoids.
Stanford researchers developed a programmable tuning circuit for dynamic, all-electronic tuning of the resonance frequency, sensitivity, and bandwidth of ultrasound transducers.
Stanford researchers have discovered a new class of metallic glass alloys with superior properties such as low cost, high wear resistance, and electric conductivity comparable to graphite.
Stanford inventors have developed a molecular design concept that allows for the development of stretchable electronics with desirable elasticity, solvent resistance, and photopatternability using covalently-embedded in-situ rubber matrix formation (iRUM).
Stanford researchers developed a device that emits electromagnetic radiation that oscillates between at least first and second distinct polarization states.
The blood-brain barrier is a huge challenge when it comes to the delivery of therapeutic proteins to treat genetic diseases, injury, and neurodegenerative diseases.
Antimicrobial peptoids are promising leads for novel antibiotics; however, their activity is often compromised under physiological conditions. Inventors at Stanford enhanced the efficacy of antimicrobial peptoids by using thiourea and thiourea derivatives.
Stanford researchers developed a novel flexible smart bandage capable of delivering precise electrical stimulation as part of an early response to wound infections.
Researchers at Stanford have developed a gene expression-based method for determining a virally infected patient's risk of developing severe symptoms, irrespective of the virus.
Stanford inventors have found that Stanniocalcin 2 (STC2) treatment following stoke leads to improved functional recovery and a pharmaceutical composition containing STC2 as an active ingredient can be used to facilitate post stroke recovery.